Medical Device Electronic Labeling Act
Summary
What This Bill Does
The bill requires allowing required labeling of devices to be made available solely by electronic means Section 502(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C and requires request for information and public comment. It relies on compliance mandates, reporting requirements, exemptions, and delegation of rulemaking. The main policy areas are Health, Healthcare, and Environment.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens and Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Environmental and public health interests affected by the bill would take on compliance duties.
Key Provisions
- Requires allowing required labeling of devices to be made available solely by electronic means Section 502(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
- Requires request for information and public comment.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires allowing required labeling of devices to be made available solely by electronic means Section 502(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C and requires request for information and public comment.
Key Policy Areas
Health, Healthcare, Environment
Primary Purpose
The bill requires allowing required labeling of devices to be made available solely by electronic means Section 502(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C and requires request for information and public comment.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Environmental and public health interests affected by the bill
- Public beneficiaries or protected communities affected by the clause
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Banks (for himself and Mr. Hickenlooper) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology